These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 5017223)
21. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis]. Utkin VV; Rudoĭ NM Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381 [No Abstract] [Full Text] [Related]
22. [Use of drug inhalation in the treatment of patients with chronic destructive pulmonary tuberculosis]. Gerasimov AI; Ganushchak MM Vrach Delo; 1972 Nov; 11():111-3. PubMed ID: 4659712 [No Abstract] [Full Text] [Related]
23. [Functional state of the kidneys in destructive pulmonary tuberculosis under antibacterial treatment]. Umarova MK; Sadykov AS; Ibragimova KhK Probl Tuberk; 1979 Feb; (2):35-8. PubMed ID: 424412 [No Abstract] [Full Text] [Related]
24. [Clinico-immunological criteria of the effectiveness of chemotherapy in patients with destructive pulmonary tuberculosis]. Ivaniuta OM; Kogosova LS; Il'nitskiĭ IG; Zamdborg IuL; Davyda RS Probl Tuberk; 1986; (2):42-5. PubMed ID: 3703842 [No Abstract] [Full Text] [Related]
25. [Chemotherapy effectiveness in destructive pulmonary tuberculosis in the middle-aged and elderly using different methods of administering the preparations]. Abrarov BA; Tursunov FI; Leĭbzon IuN; Slobodskoĭ SA; Arifov SA Probl Tuberk; 1982 Mar; (3):34-7. PubMed ID: 7088920 [No Abstract] [Full Text] [Related]
26. Relapse of tuberculosis in relation to previous treatment. Sellergren TL Scand J Respir Dis Suppl; 1970; 72():76-82. PubMed ID: 5273225 [No Abstract] [Full Text] [Related]
28. [Incidence and prevalence of chronic pulmonary tuberculosis in the Cîmpulung-Argeş district 1972-1980]. Diaconescu M; Herman PO Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(3):205-10. PubMed ID: 6296975 [TBL] [Abstract][Full Text] [Related]
29. Medical and social aspects of chronic pulmonary tuberculosis in Finland. Tani P Scand J Respir Dis Suppl; 1970; 72():93-105. PubMed ID: 5273228 [No Abstract] [Full Text] [Related]
30. [Changes of the sensitivity to tuberculin in patients with destructive pulmonary tuberculosis in the process of antibacteiial therapy]. Tsvetkova VV Probl Tuberk; 1975; (1):79-80. PubMed ID: 1144375 [No Abstract] [Full Text] [Related]
31. [Ethambutol monotherapy in chronic drug-resistant pulmonary tuberculosis]. Ferraro U; Briccarello L; Vercellino E G Ital Mal Torace; 1968; 22(4):195-201. PubMed ID: 5743001 [No Abstract] [Full Text] [Related]
32. [Multiple chemo-antibiotic therapy in pulmonary tuberculosis. Clinical and bacteriological results on 136 treated patients]. Boccitto G; De Ritis GC; Salvati F; Termine A Clin Ter; 1969 Mar; 48(5):453-64. PubMed ID: 5386429 [No Abstract] [Full Text] [Related]
33. [The efficacy of the intermittent method in the use of tuberculostatic preparations of the 1st and 2nd series in the treatment of patients with destructive forms of pulmonary tuberculosis]. Navrotskiĭ VV; Pertsovskiĭ AI; Belogurova VP Probl Tuberk; 1968; 46(11):39-43. PubMed ID: 5711714 [No Abstract] [Full Text] [Related]
34. [Early results of pulmonary tuberculosis therapy in patients over 50-year-old]. Justyńska-Lukoska R; Jórdeczka S; Szkodowa M Gruzlica; 1967 May; 35(5):429-34. PubMed ID: 6056256 [No Abstract] [Full Text] [Related]
35. [Pulmonary tuberculosis in patients over 50 years old, according to sanatorium material]. Justyńska-Lukoska R; Jórdeczka S; Szkodowa M Gruzlica; 1967 May; 35(5):421-8. PubMed ID: 6056255 [No Abstract] [Full Text] [Related]
36. [Remote results of the antibacterial therapy of destructive pulmonary tuberculosis]. Afanas'eva GS Vrach Delo; 1967 Aug; 8():65-8. PubMed ID: 5612704 [No Abstract] [Full Text] [Related]
37. [Tolerance for second-line preparations in the treatment of chronic destructive pulmonary tuberculosis]. Utkin VV Probl Tuberk; 1973; 51(9):44-9. PubMed ID: 4791465 [No Abstract] [Full Text] [Related]
39. [Classification of destructive pulmonary tuberculosis into groups according to quantitative and qualitative characteristics with the aim of developing differentiated treatment methods]. Smirnov GA; Valiev RSh Probl Tuberk; 1999; (5):11-4. PubMed ID: 10565207 [TBL] [Abstract][Full Text] [Related]